PRNewswire · Jul 2026
Mindset Health announced participation in the CMS ACCESS Model, expanding no-cost access to Nerva for eligible Original Medicare patients and reinforcing reimbursement progress for digital therapeutics.
Building AI therapeutics for physical health conditions like IBS.
Public company, workplace, funding, and market signals
Mindset Health is a Melbourne-based digital therapeutics company founded in 2019 by brothers Alex and Chris Naoumidis. It builds app-delivered brain-body programs for IBS, menopause, chronic pain, anxiety/depression, and smoking cessation, sold through consumer, clinician-referral, and health-plan/insurer access channels.
Primary product
Nerva, an app-based gut-brain therapy program for IBS
Founded
2019
Headquarters
L2, 620 Church Street, Cremorne VIC 3121, Australia
Team size
30-40
Work style
Hybrid
Industry
Digital therapeutics
Sub-industry
Behavioral health / gut-brain medicine
Offices
0 jobs at Mindset Health
Check back later for new openings
Business model
Stage
Series A
Total raised
$20.8M
Latest round
Series A · Mar 2023
Latest amount
$12M
Leadership
Co-Founder & Co-CEO
Co-Founder & Co-CEO
Chief Technology Officer
Chief Marketing Officer
Head of Finance
Head of Market Development (US)
Head of Product
Investors
Mission-driven and experimentation-oriented, with values centered on growth mindset, genuine care, transparency, figuring things out, and raising the bar. The company describes its team as builders, creatives, nerds, and learners.
Work style
Hybrid
Compensation
Public hiring materials emphasize competitive salary and equity; no public salary bands were found.
Benefits
Pricing
Consumer subscription plus insurer/health-plan coverage and referral-based access; some programs also offer trials or assistance routes.
Differentiators
Technology
Customers
Competitors
Estimated revenue
$10M-$25M
Estimated monthly visits
4.1K
Traffic estimate as of Jun 2026
PRNewswire · Jul 2026
Mindset Health announced participation in the CMS ACCESS Model, expanding no-cost access to Nerva for eligible Original Medicare patients and reinforcing reimbursement progress for digital therapeutics.
JAMA Network Open · Nov 2025
A randomized clinical trial found self-administered hypnosis significantly reduced hot flashes and daily interference, supporting the evidence base behind Evia.
Mindset Health · Mar 2025
Mindset Health announced a partnership with HIF Australia to cover its digital therapeutics suite, including Nerva, Relio, Claria, Evia, and Finito.
PRNewswire · Mar 2023
Mindset Health raised a US$12M Series A led by King River Capital, with proceeds intended for product development, global scaling, hiring, and research partnerships.
Mindset Health
The company highlights 2025 peer-reviewed trial results for Nerva and Evia and active research into biomarkers, personalization, and new indications.